Chronic benzodiazepine agonist exposure: comparison of electrophysiological changes by brain region and benzodiazepine receptor ligand
Gallager, D.W.; Wilson, M.A.
Advances in Biochemical Psychopharmacology 45: 325-336
1988
ISSN/ISBN: 0065-2229 PMID: 2845740 Document Number: 323078
Document emailed within 1 workday
Related Documents
Buck, K.J.; Harris, R.A. 1990: Benzodiazepine agonist and inverse agonist actions on GABAA receptor-operated chloride channels. II. Chronic effects of ethanol Journal of Pharmacology and Experimental Therapeutics 253(2): 713-719Squires, R.F.; Klepner, C.A.; Benson, D.I. 1980: Multiple benzodiazepine receptor complexes: some benzodiazepine recognition sites are coupled to GABA receptors and ionophores Advances in Biochemical Psychopharmacology 21: 285-293
Roy, K.; De, A.U.; Sengupta, C. 2003: QSAR of peripheral benzodiazepine receptor ligand 2-phenylimidazo-[1,2-a]pyridine derivatives with physico-chemical parameters Indian Journal of Biochemistry and Biophysics 40(3): 203-208
Speth, R.C.; Johnson, R.W.; Regan, J.; Reisine, T.; Kobayashi, R.M.; Bresolin, N.; Roeske, W.R.; Yamamura, H.I. 1980: The benzodiazepine receptor of mammalian brain Federation Proceedings 39(12): 3032-3038
De Vries, D.J.; Ward, L.C.; Wilce, P.A.; Johnston, G.A.; Shanley, B.C. 1987: Effect of ethanol on the GABA-benzodiazepine receptor in brain Alcohol and Alcoholism . Suppl 1: 663-667
Yang, X.M.; Luo, Z.P.; Zhou, J.H. 1989: Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-ethyl-6,7-dimethoxy-beta-carboline-3-carboxylate Journal of Pharmacology and Experimental Therapeutics 250(1): 358-363
Kaplan, G.B.; Greenblatt, D.J.; Leduc, B.W.; Thompson, M.L.; Shader, R.I. 1989: Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity Journal of Pharmacology and Experimental Therapeutics 248(3): 1078-1083
Andronati, S.A.; Chepelev, V.M.; Iakubovskaia, L.N.; Val'dman, A.V.; Voronina, T.A. 1983: Relationship between the structure, affinity to benzodiazepine receptors and properties of 5-halogenophenyl-1,2-dihydro-3H-1,4- benzodiazepine-2-ones Bioorganicheskaia Khimiia 9(10): 1357-1361
Rozhanets, V.V.; Rusakov, D.I.; Danchev, N.D.; Val'dman, A.V. 1983: Effect of chronic use of antidepressants on the state of benzodiazepine receptors in the mouse brain Biulleten' Eksperimental'noi Biologii i Meditsiny 96(7): 46-48
Sansone, M.; Castellano, C.; Pavone, F.; Hano, J. 1985: Opioid benzodiazepine tifluadom and drug-induced hyperactivity in mice: lack of benzodiazepine-like effects Polish Journal of Pharmacology and Pharmacy 37(5): 585-590
Di Braccio, M.; Roma, G.; Grossi, G.C.; Leoncini, G.; Maresca, M. 1992: 1,5-Benzodiazepines. X. Dialkylamino substituted 1,5-benzodiazepine and [1,2,4]triazolo [4,3-a][1,5] benzodiazepine derivatives with inhibitory activity on PAF-induced platelet aggregation Farmaco 47(1): 77-90
Sieghart, W.; Drexler, G.; Mayer, A.; Schuster, A. 1983: Interaction of benzodiazepine agonists and antagonists with different benzodiazepine receptors Advances in Biochemical Psychopharmacology 38: 11-19
Golovko, A.I.; Sofronov, G.A.; Kliuntina, T.V. 1993: N-methyl-3H]methylphenazepam--a new ligand for benzodiazepine receptors Biulleten' Eksperimental'noi Biologii i Meditsiny 115(4): 382-383
Gee, K.W.; Ehlert, F.J.; Yamamura, H.I. 1983: Differential effect of gamma-aminobutyric acid on benzodiazepine receptor subtypes labeled by [3H]propyl beta-carboline-3-carboxylate in rat brain Journal of Pharmacology and Experimental Therapeutics 225(1): 132-137
Abbracchio, M.P.; Balduini, W.; Coen, E.; Lombardelli, G.; Peruzzi, G.; Cattabeni, F. 1983: Chronic chlordiazepoxide treatment on adult and newborn rats: effect on the GABA-benzodiazepine receptor complex Advances in Biochemical Psychopharmacology 38: 227-237
Hirsch, J.D.; Beyer, C.F.; Malkowitz, L.; Loullis, C.C.; Blume, A.J. 1989: Characterization of ligand binding to mitochondrial benzodiazepine receptors Molecular Pharmacology 35(1): 164-172
Roma, G.; Ermili, A.; Balbi, A. 1977: Studies on 1,5-benzodiazepine. I. Derivatives of 4-amino-1,5-benzodiazepine Il Farmaco; Edizione Scientifica 32(2): 81-91
Miller, L.G.; Greenblatt, D.J.; Roy, R.B.; Summer, W.R.; Shader, R.I. 1988: Chronic benzodiazepine administration. II. Discontinuation syndrome is associated with upregulation of gamma-aminobutyric acidA receptor complex binding and function Journal of Pharmacology and Experimental Therapeutics 246(1): 177-182
Jenck, F.; Moreau, J.L.; Bonetti, E.P.; Martin, J.R.; Haefely, W.E. 1992: Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic Journal of Pharmacology and Experimental Therapeutics 262(3): 1121-1127
Ballenger, J.C.; McDonald, S.; Noyes, R.; Rickels, K.; Sussman, N.; Woods, S.; Patin, J.; Singer, J. 1991: The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist abecarnil (ZK 112-119) in generalized anxiety disorder Psychopharmacology Bulletin 27(2): 171-179